Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2022-12-29 Sale | 2024-03-14 5:02 pm | Shuttle Pharmaceuticals Holdings Inc. | SHPH | Senanayake Chris Director | 1,626 | $1.605 | $2,610 | 2,791 (Direct) | View |
2023-12-13 Sale | 2024-01-02 5:10 pm | Shuttle Pharmaceuticals Holdings Inc. | SHPH | Brown Milton Director | 2,921 | $0.4632 | $1,353 | 1,094,610 (Direct) | View |
2023-12-13 Sale | 2023-12-20 9:51 pm | Shuttle Pharmaceuticals Holdings Inc. | SHPH | Jacobs Bette Director | 4,157 | $0.4632 | $1,926 | 27,064 (Direct) | View |
2022-12-29 Sale | 2023-01-09 4:10 pm | Shuttle Pharmaceuticals Holdings Inc. | SHPH | Richards Steven M Director | 995 | $1.605 | $1,597 | 1,707 (Direct) | View |
2022-12-29 Sale | 2023-01-04 4:10 pm | Shuttle Pharmaceuticals Holdings Inc. | SHPH | Adkins William Former Director Director | 995 | $1.605 | $1,597 | 322,960 (Direct) | View |
2022-12-29 Sale | 2023-01-04 4:10 pm | Shuttle Pharmaceuticals Holdings Inc. | SHPH | Brown Milton Director | 995 | $1.605 | $1,597 | 1,072,531 (Direct) | View |
2022-12-29 Sale | 2023-01-03 06:20 am | Shuttle Pharmaceuticals Holdings Inc. | SHPH | Dritschilo Anatoly CEO and Chairman 10% Owner | 8,372 | $1.605 | $13,437 | 4,289,607 (Indirect Direct) | View |
2022-12-29 Sale | 2023-01-03 06:10 am | Shuttle Pharmaceuticals Holdings Inc. | SHPH | Rich Tyvin Chief Medical Officer | 1,414 | $1.605 | $2,269 | 2,429 (Direct) | View |
2022-12-29 Sale | 2023-01-03 06:10 am | Shuttle Pharmaceuticals Holdings Inc. | SHPH | Jung Mira Chief Scientific Officer | 328 | $1.605 | $526 | 1,071,388 (Direct) | View |
2022-12-29 Sale | 2023-01-03 06:10 am | Shuttle Pharmaceuticals Holdings Inc. | SHPH | Jacobs Bette Director | 4,366 | $1.605 | $7,007 | 31,221 (Direct) | View |
2022-12-29 Sale | 2022-12-30 8:48 pm | Shuttle Pharmaceuticals Holdings Inc. | SHPH | Dritschilo Peter President and COO | 3,820 | $1.605 | $6,131 | 6,560 (Direct) | View |
2022-12-29 Sale | 2022-12-30 4:06 pm | Shuttle Pharmaceuticals Holdings Inc. | SHPH | Vander Hoek Michael Chief Financial Officer | 2,243 | $1.605 | $3,600 | 3,852 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-05-01 Option Award | 2024-10-09 5:00 pm | N/A N/A | Shuttle Pharmaceuticals Holdings Inc. | SHPH | Jung Mira Chief Scientific Officer | 598 | $11.28 | 135,715 (Direct) | View |
Ownership | 2024-06-25 5:42 pm | N/A N/A | Shuttle Pharmaceuticals Holdings Inc. | SHPH | Lorber Timothy J. Chief Financial Officer | 0 | $0 | 227,635 (Direct) | View |
2024-03-08 Option Award | 2024-03-08 6:18 pm | N/A N/A | Shuttle Pharmaceuticals Holdings Inc. | SHPH | Vander Hoek Michael Chief Financial Officer | 100,000 | $0 | 103,852 (Direct) | View |
2023-08-14 Gift | 2023-08-18 7:48 pm | N/A N/A | Shuttle Pharmaceuticals Holdings Inc. | SHPH | Dritschilo Anatoly CEO and Chairman 10% Owner | 2,100,000 | $0 | 2,100,000 (Indirect) | View |
2023-02-15 Option Award | 2023-02-17 08:29 am | 2024-02-15 2028-02-15 | Shuttle Pharmaceuticals Holdings Inc. | SHPH | Brown Milton Director | 25,000 | $0 | 25,000 (Direct) | View |
2022-09-02 Other | 2023-01-04 4:10 pm | 2022-09-02 2025-09-02 | Shuttle Pharmaceuticals Holdings Inc. | SHPH | Adkins William Former Director Director | 138,889 | $0 | 322,960 (Direct) | View |
Ownership | 2022-11-09 10:11 am | N/A N/A | Shuttle Pharmaceuticals Holdings Inc. | SHPH | Jacobs Bette Director | 0 | $0 | 35,587 (Direct) | View |
Ownership | 2022-09-09 4:05 pm | N/A N/A | Shuttle Pharmaceuticals Holdings Inc. | SHPH | Brown Milton Director | 0 | $0 | 1,073,526 (Direct) | View |
Ownership(A) | 2022-09-08 09:11 am | N/A N/A | Shuttle Pharmaceuticals Holdings Inc. | SHPH | Dritschilo Anatoly CEO and Chairman 10% Owner | 0 | $0 | 1,093,572 (Direct) | View |
Ownership | 2022-09-07 8:48 pm | N/A N/A | Shuttle Pharmaceuticals Holdings Inc. | SHPH | Richards Steven M Director | 0 | $0 | 2,702 (Direct) | View |
Ownership | 2022-09-07 4:05 pm | N/A N/A | Shuttle Pharmaceuticals Holdings Inc. | SHPH | Senanayake Chris Director | 0 | $0 | 3,843 (Direct) | View |
Ownership | 2022-09-07 09:25 am | N/A N/A | Shuttle Pharmaceuticals Holdings Inc. | SHPH | Adkins William Director | 0 | $0 | 280,480 (Direct) | View |
Ownership | 2022-09-07 09:24 am | N/A N/A | Shuttle Pharmaceuticals Holdings Inc. | SHPH | Rich Tyvin Chief Medical Officer | 0 | $0 | 3,843 (Direct) | View |
Ownership | 2022-09-07 09:22 am | N/A N/A | Shuttle Pharmaceuticals Holdings Inc. | SHPH | Dritschilo Peter President and COO | 0 | $0 | 10,380 (Direct) | View |
Ownership | 2022-09-07 09:21 am | N/A N/A | Shuttle Pharmaceuticals Holdings Inc. | SHPH | Jung Mira Chief Scientific Officer | 0 | $0 | 1,071,716 (Direct) | View |
Ownership | 2022-09-07 09:20 am | N/A N/A | Shuttle Pharmaceuticals Holdings Inc. | SHPH | Vander Hoek Michael Chief Financial Officer | 0 | $0 | 6,095 (Direct) | View |
Ownership | 2022-09-07 09:19 am | N/A N/A | Shuttle Pharmaceuticals Holdings Inc. | SHPH | Schafer Joshua Director | 0 | $0 | 2,702 (Direct) | View |
Ownership | 2022-09-07 09:18 am | N/A N/A | Shuttle Pharmaceuticals Holdings Inc. | SHPH | Dritschilo Anatoly CEO and Chairman 10% Owner | 0 | $0 | 4,275,231 (Direct) | View |